Related Experiment Video
Updated: Feb 24, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Caregiving for children with type 1 diabetes and clinical outcomes in central India: The IDREAM study
Greta Friedemann-Sánchez1, Beatrix D Capistrant2,3, James Ron4,5
1Hubert H. Humphrey School of Public Affairs, University of Minnesota, Minneapolis, Minnesota.
Insights
Parental involvement in managing type 1 diabetes (T1D) is crucial for better glycemic control in children. Caregiver participation in insulin delivery tasks significantly lowers hemoglobin A1c (HbA1c) levels, especially in younger children.
Area of Science:
- Pediatrics
- Endocrinology
- Public Health
Background:
- Parental caregiving significantly impacts health outcomes for children with type 1 diabetes (T1D).
- Evidence on parental caregiving in developing countries, with conventional insulin therapy and limited glucose monitoring, is scarce.
- This study examines the role of parental involvement in T1D management tasks and its effect on glycemic control.
Purpose of the Study:
- To investigate the association between parental performance of key T1D management tasks and hemoglobin A1c (HbA1c) levels in children.
- To explore how this association varies by child age and duration of diabetes diagnosis.
Main Methods:
- A survey of caregivers of 179 children with T1D in Maharashtra, India.
- Linear regression analysis to assess the relationship between parental caregiving and HbA1c.
- Analysis stratified by child age and time since diagnosis.
Main Results:
- Parental involvement in insulin delivery was linked to lower HbA1c levels across all children.
- Reductions in HbA1c were most pronounced in children aged 11-14 years diagnosed for less than 2 years.
- Children with caregiver-performed tasks had a mean HbA1c of 8.5% versus 14.4% for child-performed tasks.
Conclusions:
- Parental involvement in T1D care is vital, particularly for children diagnosed early.
- Reduced parental involvement in later childhood/adolescence is associated with poorer glycemic control.
- Healthcare providers should identify who performs T1D tasks and tailor education accordingly.
Aims:
Parental care influences outcomes for children's type 1 diabetes (T1D). There is little evidence about the impact of parental caregiving in developing countries, where fixed dose human insulin (conventional) therapy and limited self-monitoring of blood glucose are common. This article investigates whether performance of key T1D management tasks by children or their caregivers impacts hemoglobin A1c (HbA1c).
Methods:
We surveyed the caregivers of 179 children with T1D routinely treated in a specialized diabetes clinic in Maharashtra, India to determine who performs key diabetes care tasks: child or parent. We used linear regression to estimate the relationship between parental caregiving and HbA1c, and how this association varies by child age and time since diagnosis.
Results:
Caregivers of older children were less involved in care tasks, though caregivers of 11- to 18-year olds performed more care for children diagnosed for a longer duration. Parental involvement in key insulin delivery tasks was associated with lower HbA1c levels for all children. These reductions were greatest among children 11 to 14 years old and diagnosed for less than 2 years: mean HbA1c levels were 8.5% (69 mmol/mol) if the caregiver, and 14.4% (134 mmol/mol) if the child, performed the tasks (P < .05).
Conclusion:
Parents of children diagnosed with T1D early in life remain involved in care throughout the child's adolescence. Parents of children diagnosed in late childhood and early adolescence are significantly less involved in care, and this is associated with worse glycemic control. Clinics must know who performs care tasks and tailor diabetes education appropriately.
Related Concept Videos
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...

